"Designing Growth Strategies is in our DNA"

Multiple Sclerosis Drugs Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Immunomodulators, Immunosuppressants, Interferons, and Others), By Route of Administration (Oral and Injection (Intramuscular, Subcutaneous, and Intravenous) By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Regional Forecast, 2021-2028

Region : Global | Format: PDF | Report ID: FBI100386

 

Table of Content:

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Multiple Sclerosis – For Key Countries
    2. Regulatory & Reimbursement Overview – For Key Countries
    3. Pipeline Analysis
    4. Patent Snapshot
    5. New Product Launches
    6. Key Industry Developments - Mergers, Acquisitions and Partnerships
  5. Global Multiple Sclerosis Drugs Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Class
      1. Immunomodulators
      2. Immunosuppressants
      3. Interferons
      4. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Injection
        1. Intramuscular
        2. Subcutaneous
        3. Intravenous
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Multiple Sclerosis Drugs Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Class
      1. Immunomodulators
      2. Immunosuppressants
      3. Interferons
      4. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Injection
        1. Intramuscular
        2. Subcutaneous
        3. Intravenous
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Multiple Sclerosis Drugs Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Class
      1. Immunomodulators
      2. Immunosuppressants
      3. Interferons
      4. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Injection
        1. Intramuscular
        2. Subcutaneous
        3. Intravenous
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. Market Analysis, Insights and Forecast – By Countries/ Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Multiple Sclerosis Drugs Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Class
      1. Immunomodulators
      2. Immunosuppressants
      3. Interferons
      4. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Injection
        1. Intramuscular
        2. Subcutaneous
        3. Intravenous
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. Market Analysis, Insights and Forecast – By Countries/ Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Multiple Sclerosis Drugs Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Class
      1. Immunomodulators
      2. Immunosuppressants
      3. Interferons
      4. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Injection
        1. Intramuscular
        2. Subcutaneous
        3. Intravenous
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. Market Analysis, Insights and Forecast – By Countries/ Sub regions
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Multiple Sclerosis Drugs Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Class
      1. Immunomodulators
      2. Immunosuppressants
      3. Interferons
      4. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Injection
        1. Intramuscular
        2. Subcutaneous
        3. Intravenous
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. Market Analysis, Insights and Forecast – By Countries/ Sub region
      1. South Africa
      2. GCC
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2020)
    3. Company Profiles (Overview, Product & Services, SWOT analysis, Recent developments, strategies, financials (based on availability))
      1. Biogen
        1. Overview,
        2. Product & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      2. Pfizer Inc.
        1. Overview,
        2. Product & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. Novartis AG
        1. Overview,
        2. Product & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. F.Hoffmann-La Roche Ltd.AstraZeneca
        1. Overview,
        2. Product & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      5. Merck & Co., Inc.
        1. Overview,
        2. Product & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      6. Sanofi
        1. Overview,
        2. Product & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      7. Teva Pharmaceuticals Industries Ltd.
        1. Overview,
        2. Product & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      8. Bristol-Myers Squibb Company
        1. Overview,
        2. Product & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      9. Other Prominent Players
        1. Overview,
        2. Product & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
  12. Strategic Recommendations

List of Figures

Figure 1:  Global Multiple Sclerosis Drugs Market Revenue Breakdown (USD Billion, %) by Region, 2020 & 2028

Figure 2:  Global Multiple Sclerosis Drugs Market Value Share (%), by Drug Class, 2020 & 2028                      

Figure 3:  Global Multiple Sclerosis Drugs Market Forecast (USD Billion), by Immunomodulators, 2017-2028             

Figure 4:  Global Multiple Sclerosis Drugs Market Forecast (USD Billion), by Immunosuppressants, 2017-2028           

Figure 5:  Global Multiple Sclerosis Drugs Market Forecast (USD Billion), by Interferons, 2017-2028                             

Figure 6:  Global Multiple Sclerosis Drugs Market Forecast (USD Billion), by Others, 2017-2028                     

Figure 7:  Global Multiple Sclerosis Drugs Market Value Share (%), by Route of Administration, 2020 & 2028

Figure 8:  Global Multiple Sclerosis Drugs Market Forecast (USD Billion), by Oral, 2017-2028                          

Figure 9:  Global Multiple Sclerosis Drugs Market Forecast (USD Billion), by Injection, 2017-2028  

Figure 10:  Global Multiple Sclerosis Drugs Market Value Share (%), by Distribution Channel, 2020 & 2028 

Figure 11:  Global Multiple Sclerosis Drugs Market Forecast (USD Billion), by Hospital Pharmacy, 2017-2028              

Figure 12:  Global Multiple Sclerosis Drugs Market Forecast (USD Billion), by Retail Pharmacy, 2017-2028

Figure 13:  Global Multiple Sclerosis Drugs Market Forecast (USD Billion), by Online Pharmacy, 2017-2028

Figure 14:  Global Multiple Sclerosis Drugs Market Value (USD Billion), by Region, 2020 & 2028                     

Figure 15:  North America Multiple Sclerosis Drugs Market Value (USD Billion), by Drug Class, 2020 & 2028                

Figure 16:  North America Multiple Sclerosis Drugs Market Value Share (%), by Drug Class, 2020                   

Figure 17:  North America Multiple Sclerosis Drugs Market Value (USD Billion), by Route of Administration, 2020 & 2028                               

Figure 18:  North America Multiple Sclerosis Drugs Market Value Share (%), by Route of Administration, 2020

Figure 19:  North America Multiple Sclerosis Drugs Market Value (USD Billion), by Distribution Channel, 2020 & 2028

Figure 20:  North America Multiple Sclerosis Drugs Market Value Share (%), by Distribution Channel, 2020

Figure 21:  North America Multiple Sclerosis Drugs Market Value (USD Billion), By Country, 2020 & 2028    

Figure 22:  North America Multiple Sclerosis Drugs Market Value Share (%), By Country, 2020                                       

Figure 23:  Europe Multiple Sclerosis Drugs Market Value (USD Billion), by Drug Class, 2020 & 2028                                             

Figure 24:  Europe Multiple Sclerosis Drugs Market Value Share (%), by Drug Class, 2020 

Figure 25:  Europe Multiple Sclerosis Drugs Market Value (USD Billion), by Route of Administration, 2020 & 2028

Figure 26:  Europe Multiple Sclerosis Drugs Market Value Share (%), by Route of Administration, 2020

Figure 27:  Europe Multiple Sclerosis Drugs Market Value (USD Billion), by Distribution Channel, 2020 & 2028           

Figure 28:  Europe Multiple Sclerosis Drugs Market Value Share (%), by Distribution Channel, 2020

Figure 29:  Europe Multiple Sclerosis Drugs Market Value (USD Billion), By Country/ Sub-region, 2020 & 2028           

Figure 30:  Europe Multiple Sclerosis Drugs Market Value Share (%), By Country/ Sub-region, 2020

Figure 31:  Asia Pacific Multiple Sclerosis Drugs Market Value (USD Billion), by Drug Class, 2020 & 2028

Figure 32:  Asia Pacific Multiple Sclerosis Drugs Market Value Share (%), by Drug Class, 2020

Figure 33:  Asia Pacific Multiple Sclerosis Drugs Market Value (USD Billion), by Route of Administration, 2020 & 2028

Figure 34:  Asia Pacific Multiple Sclerosis Drugs Market Value Share (%), by Route of Administration, 2020

Figure 35:  Asia Pacific Multiple Sclerosis Drugs Market Value (USD Billion), by Distribution Channel, 2020 & 2028

Figure 36:  Asia Pacific Multiple Sclerosis Drugs Market Value Share (%), by Distribution Channel, 2020

Figure 37:  Asia Pacific Multiple Sclerosis Drugs Market Value (USD Billion), By Country/ Sub-region, 2020 & 2028

Figure 38:  Asia Pacific Multiple Sclerosis Drugs Market Value Share (%), By Country/ Sub-region, 2020       

Figure 39:  Latin America Multiple Sclerosis Drugs Market Value (USD Billion), by Drug Class, 2020 & 2028

Figure 40:  Latin America Multiple Sclerosis Drugs Market Value Share (%), by Drug Class, 2020                     

Figure 41:  Latin America Multiple Sclerosis Drugs Market Value (USD Billion), by Route of Administration, 2020 & 2028         

Figure 42:  Latin America Multiple Sclerosis Drugs Market Value Share (%), by Route of Administration, 2020

Figure 43:  Latin America Multiple Sclerosis Drugs Market Value (USD Billion), by Distribution Channel, 2020 & 2028

Figure 44:  Latin America Multiple Sclerosis Drugs Market Value Share (%), by Distribution Channel, 2020  

Figure 45:  Latin America Multiple Sclerosis Drugs Market Value (USD Billion), By Country/ Sub-region, 2020 & 2028

Figure 46:  Latin America Multiple Sclerosis Drugs Market Value Share (%), By Country/ Sub-region, 2020   

Figure 47:  Middle East & Africa Multiple Sclerosis Drugs Market Value (USD Billion), by Drug Class, 2020 & 2028

Figure 48:  Middle East & Africa Multiple Sclerosis Drugs Market Value Share (%), by Drug Class, 2020

Figure 49:  Middle East & Africa Multiple Sclerosis Drugs Market Value (USD Billion), by Route of Administration, 2020 & 2028             

Figure 50:  Middle East & Africa Multiple Sclerosis Drugs Market Value Share (%), by Route of Administration, 2020

Figure 51:  Middle East & Africa Multiple Sclerosis Drugs Market Value (USD Billion), by Distribution Channel, 2020 & 2028                 

Figure 52:  Middle East & Africa Multiple Sclerosis Drugs Market Value Share (%), by Distribution Channel, 2020      

Figure 53:  Middle East & Africa Multiple Sclerosis Drugs Market Value (USD Billion), By Country/ Sub-region, 2020 & 2028                 

Figure 54:  Middle East & Africa Multiple Sclerosis Drugs Market Value Share (%), By Country/ Sub-region, 2020

Figure 55:  Global Multiple Sclerosis Drugs Market Share (%), By Company, 2020               

List of Tables

Table 1:  Global Multiple Sclerosis Drugs Market Revenue (USD Billion) Forecast, by Drug Class, 2017-2028

Table 2:  Global Multiple Sclerosis Drugs Market Revenue (USD Billion) Forecast, by Route of Administration, 2017-2028

Table 3:  Global Multiple Sclerosis Drugs Market Revenue (USD Billion) Forecast, by Injection, 2017-2028

Table 4:  Global Multiple Sclerosis Drugs Market Revenue (USD Billion) Forecast, by Distribution Channel, 2017-2028

Table 5:  Global Multiple Sclerosis Drugs Market Revenue (USD Billion) Forecast, by Region, 2017-2028

Table 6:  North America Multiple Sclerosis Drugs Market Revenue (USD Billion) Forecast, by Drug Class, 2017-2028

Table 7:  North America Multiple Sclerosis Drugs Market Revenue (USD Billion) Forecast, by Route of Administration, 2017-2028

Table 8:  North America Multiple Sclerosis Drugs Market Revenue (USD Billion) Forecast, by Injection, 2017-2028

Table 9:  North America Multiple Sclerosis Drugs Market Revenue (USD Billion) Forecast, by Distribution Channel, 2017-2028

Table 10:  North America Multiple Sclerosis Drugs Market Revenue (USD Billion) Forecast, By Country, 2017-2028

Table 11:  Europe Multiple Sclerosis Drugs Market Revenue (USD Billion) Forecast, by Drug Class, 2017-2028

Table 12:  Europe Multiple Sclerosis Drugs Market Revenue (USD Billion) Forecast, by Route of Administration, 2017-2028

Table 13:  Europe Multiple Sclerosis Drugs Market Revenue (USD Billion) Forecast, by Injection, 2017-2028

Table 14:  Europe Multiple Sclerosis Drugs Market Revenue (USD Billion) Forecast, by Distribution Channel, 2017-2028

Table 15:  Europe Multiple Sclerosis Drugs Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2017-2028

Table 16:  Asia Pacific Multiple Sclerosis Drugs Market Revenue (USD Billion) Forecast, by Drug Class, 2017-2028

Table 17:  Asia Pacific Multiple Sclerosis Drugs Market Revenue (USD Billion) Forecast, by Route of Administration, 2017-2028

Table 18:  Asia Pacific Multiple Sclerosis Drugs Market Revenue (USD Billion) Forecast, by Injection, 2017-2028

Table 19:  Asia Pacific Multiple Sclerosis Drugs Market Revenue (USD Billion) Forecast, by Distribution Channel, 2017-2028

Table 20:  Asia Pacific Multiple Sclerosis Drugs Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2017-2028

Table 21:  Latin America Multiple Sclerosis Drugs Market Revenue (USD Billion) Forecast, by Drug Class, 2017-2028

Table 22:  Latin America Multiple Sclerosis Drugs Market Revenue (USD Billion) Forecast, by Route of Administration, 2017-2028

Table 23:  Latin America Multiple Sclerosis Drugs Market Revenue (USD Billion) Forecast, by Injection, 2017-2028

Table 24:  Latin America Multiple Sclerosis Drugs Market Revenue (USD Billion) Forecast, by Distribution Channel, 2017-2028

Table 25:  Latin America Multiple Sclerosis Drugs Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2017-2028

Table 26:  Middle East & Africa Multiple Sclerosis Drugs Market Revenue (USD Billion) Forecast, by Drug Class, 2017-2028

Table 27:  Middle East & Africa Multiple Sclerosis Drugs Market Revenue (USD Billion) Forecast, by Route of Administration, 2017-2028

Table 28:  Middle East & Africa Multiple Sclerosis Drugs Market Revenue (USD Billion) Forecast, by Injection, 2017-2028

Table 29:  Middle East & Africa Multiple Sclerosis Drugs Market Revenue (USD Billion) Forecast, by Distribution Channel, 2017-2028

Table 30:  Middle East & Africa Multiple Sclerosis Drugs Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2017-2028

 class=
  • Jun, 2021
  • 2020
  • 2017-2019
  • 160

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X